| Financial Year |
March 31 2023 |
| Monetary Funds |
180,012,984.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,660,942.85 |
| Accounts Receivable |
440,815,509.59 |
| Advances to Suppliers |
3,831,991.98 |
| Other Receivables |
3,077,305.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,218,645.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,813,637.23 |
| Total Current Assets |
906,669,223.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
839,198,069.90 |
| Investment Properties |
71,874,044.13 |
| Fixed Assetes |
200,433,539.12 |
| Under-construction Projects |
75,182,959.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,976,385.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,444,867.63 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,257,830,043.29 |
| Total Assets |
4,164,499,266.29 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
89,737,044.49 |
| Accounts Received In Advance |
52,380,952.40 |
| Employee Compensation Payable |
816,198.53 |
| Taxes Payable |
56,164,197.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
420,842,115.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
50,822,519.25 |
| Sub-Total of Current Liabilities |
1,020,131,302.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
266,719,438.98 |
| Other Non-Current Liabilities |
133,647,817.29 |
| Sub-Total of Non-Current Liabilities |
400,367,256.27 |
| Total Liabilities |
1,420,498,558.96 |
| Paid-In Capital(Or Share Stock) |
441,575,416.00 |
| Capital Surplus |
520,663,541.11 |
| Surplus Reserve |
160,062,513.61 |
| LESS:Treasury Stock |
99,990,579.80 |
| Undistributed Profits |
1,721,689,816.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,744,000,707.33 |
| Owner's Equity（Stockholder's Equity） |
2,744,000,707.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,164,499,266.29 |
